Julie C. Friedland

1.5k total citations · 1 hit paper
11 papers, 1.2k citations indexed

About

Julie C. Friedland is a scholar working on Molecular Biology, Computational Theory and Mathematics and Immunology and Allergy. According to data from OpenAlex, Julie C. Friedland has authored 11 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Computational Theory and Mathematics and 2 papers in Immunology and Allergy. Recurrent topics in Julie C. Friedland's work include Heat shock proteins research (6 papers), ATP Synthase and ATPases Research (3 papers) and Computational Drug Discovery Methods (2 papers). Julie C. Friedland is often cited by papers focused on Heat shock proteins research (6 papers), ATP Synthase and ATPases Research (3 papers) and Computational Drug Discovery Methods (2 papers). Julie C. Friedland collaborates with scholars based in United States and Ireland. Julie C. Friedland's co-authors include David Boettiger, Mark H. Lee, David A. Proia, Jaime Acquaviva, Chaohua Zhang, Suqin He, Jim Sang, Donald L. Smith, Manuel Sequeira and Ming Ouyang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Julie C. Friedland

11 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanically Activated Integrin Switch Controls α ₅ β ₁ Function

2009 573 citations Julie C. Friedland, Mark H. Lee et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie C. Friedland United States	8	538	462	272	220	193	11	1.2k
Yeh‐Shiu Chu Taiwan	17	727 1.4×	752 1.6×	131 0.5×	382 1.7×	99 0.5×	26	1.8k
Mingxing Ouyang United States	20	912 1.7×	1.1k 2.4×	335 1.2×	219 1.0×	68 0.4×	44	2.1k
Anna Chrostek‐Grashoff Germany	14	601 1.1×	625 1.4×	176 0.6×	78 0.4×	39 0.2×	15	1.3k
Olga Krylyshkina Austria	12	518 1.0×	934 2.0×	274 1.0×	108 0.5×	32 0.2×	14	1.3k
Johan A. Slotman Netherlands	19	467 0.9×	275 0.6×	78 0.3×	67 0.3×	71 0.4×	46	1.0k
Eric M. Balzer United States	17	596 1.1×	557 1.2×	83 0.3×	428 1.9×	48 0.2×	27	1.3k
Melanie Barzik United States	13	524 1.0×	637 1.4×	140 0.5×	77 0.3×	23 0.1×	17	1.1k
Kevin C. Flynn United States	17	902 1.7×	927 2.0×	117 0.4×	111 0.5×	83 0.4×	22	2.4k
Vladislav Soroka Denmark	19	989 1.8×	293 0.6×	119 0.4×	75 0.3×	79 0.4×	30	1.6k
Pauline Gonnord France	9	635 1.2×	582 1.3×	60 0.2×	87 0.4×	37 0.2×	11	1.2k

Countries citing papers authored by Julie C. Friedland

Since Specialization

Citations

This map shows the geographic impact of Julie C. Friedland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie C. Friedland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie C. Friedland more than expected).

Fields of papers citing papers by Julie C. Friedland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie C. Friedland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie C. Friedland. The network helps show where Julie C. Friedland may publish in the future.

Co-authorship network of co-authors of Julie C. Friedland

This figure shows the co-authorship network connecting the top 25 collaborators of Julie C. Friedland. A scholar is included among the top collaborators of Julie C. Friedland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie C. Friedland. Julie C. Friedland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Friedland, Julie C., Aaron U. Blackham, Alyson McIntosh, et al.. (2022). Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma. Melanoma Research. 32(4). 295–298. 6 indexed citations

Friedland, Julie C., Donald L. Smith, Jim Sang, et al.. (2013). Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes. Investigational New Drugs. 32(1). 14–24. 46 indexed citations

Sang, Jim, Jaime Acquaviva, Julie C. Friedland, et al.. (2013). Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer. Cancer Discovery. 3(4). 430–443. 174 indexed citations

He, Suqin, Jaime Acquaviva, Julie C. Friedland, et al.. (2013). Abstract 1038: Inhibition of mTOR enhances the activity of HSP90 inhibitors in part through cessation of heat shock protein synthesis.. Cancer Research. 73(8_Supplement). 1038–1038. 1 indexed citations

Acquaviva, Jaime, Donald L. Smith, Jim Sang, et al.. (2012). Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib. Molecular Cancer Therapeutics. 11(12). 2633–2643. 83 indexed citations

He, Suqin, Chaohua Zhang, Ayesha A. Shafi, et al.. (2012). Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression. International Journal of Oncology. 42(1). 35–43. 50 indexed citations

Proia, David A., Jaime Acquaviva, Qin Jiang, et al.. (2012). Preclinical activity of the Hsp90 inhibitor, ganetespib, in ALK- and ROS1-driven cancers.. Journal of Clinical Oncology. 30(15_suppl). 3090–3090. 3 indexed citations

Friedland, Julie C., Mark H. Lee, & David Boettiger. (2009). Mechanically Activated Integrin Switch Controls α ₅ β ₁ Function. Science. 323(5914). 642–644. 573 indexed citations breakdown →

Friedland, Julie C., Johnathon N. Lakins, Marcelo G. Kazanietz, et al.. (2007). α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini. Journal of Cell Science. 120(20). 3700–3712. 70 indexed citations

10.

Cryan, John F., Olivia F. O’Leary, Sung‐Ha Jin, et al.. (2004). Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proceedings of the National Academy of Sciences. 101(21). 8186–8191. 179 indexed citations

11.

Otori, Tatsuo, Julie C. Friedland, Grant Sinson, et al.. (2004). Traumatic Brain Injury Elevates Glycogen and Induces Tolerance to Ischemia in Rat Brain. Journal of Neurotrauma. 21(6). 707–718. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact